SUPPRESSION OF IN-VITRO TYPE-17 RESPONSES IN SPA PATIENTS USING SMALL MOLECULE ROR-gamma T INHIBITORS
Κύριοι συγγραφείς: | De Wit, J, Al-Mossawi, M, Huhn, M, Arancibia, C, Powrie, F, Bowness, P |
---|---|
Μορφή: | Journal article |
Έκδοση: |
2014
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
RORγt inhibitors suppress TH17 responses in inflammatory arthritis and inflammatory bowel disease.
ανά: de Wit, J, κ.ά.
Έκδοση: (2015) -
Small molecule inhibitors of RORγt for Th17 regulation in inflammatory and autoimmune diseases
ανά: Jiuping Zeng, κ.ά.
Έκδοση: (2023-06-01) -
BROMODOMAIN INHIBITORS REDUCE TH17-TYPE RESPONSES IN SPONDYLOARTHRITIS IN VITRO
ανά: Hammitzsch, A, κ.ά.
Έκδοση: (2014) -
Small molecule allosteric inhibitors of RORγt block Th17-dependent inflammation and associated gene expression in vivo.
ανά: Steven A Saenz, κ.ά.
Έκδοση: (2021-01-01) -
Small molecule allosteric inhibitors of RORγt block Th17-dependent inflammation and associated gene expression in vivo
ανά: Steven A. Saenz, κ.ά.
Έκδοση: (2021-01-01)